The antibiotic sector is one of the segments phased by the influx of new entrants into the market having price variations that are way below the price cap of the innovator brands/market leaders. Building on the economic situation plaguing the world with Nigeria having its fair share, most market leaders are barely seen struggling to compete for a share in the densely populated market.